(2-arylhydrazonomethyl)-substituted xanthones as antimycotics:: synthesis and fungistatic activity against Candida species

被引:22
作者
Moreau, S [1 ]
Verache-Lembège, M [1 ]
Larrouture, S [1 ]
Fall, D [1 ]
Neveu, A [1 ]
Deffieux, G [1 ]
Vercauteren, J [1 ]
Nuhrich, A [1 ]
机构
[1] Univ Victor Segalen Bordeaux 2, Grp Etud Subst Nat Interet Therapeut GESNIT, EA 491, F-33076 Bordeaux, France
关键词
arylhydrazono-xanthones; synthesis; structural study; in vitro anticandida activity;
D O I
10.1016/S0223-5234(01)01332-0
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of arylhydrazones derived from various 6,8-diacetoxy- or 6,8-dihydroxy-9-oxo-9H-xanthene carboxaldehydes were synthesized and evaluated for their in vitro antifungal properties against two human pathogenic yeasts (Candida albicans and C. krusei) according to a diffusion method. The activity was strongly dependent from the position of the (1-arylhydrazinyl-2-ylidene)methyl chain in the xanthone molecular skeleton. Compounds having the nitrogen side chain in the 4-position, with a further halogen substitution on the terminal phenyl ring showed fungistatic effects. Within this series, the 4-fluorophenylhydrazinyl derivative 13g exhibited the highest activity, particularly against C. krusei, with a greater efficacy than that of econazole, used as reference. (C) 2002 Published by Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:237 / 253
页数:17
相关论文
共 36 条
[1]   Candida krusei fungemia -: An escalating serious infection in immunocompromised patients [J].
Abbas, J ;
Bodey, GP ;
Hanna, HA ;
Mardani, M ;
Girgawy, E ;
Abi-Said, D ;
Whimbey, E ;
Hachem, R ;
Raad, I .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (17) :2659-2664
[2]   Current and future antifungal therapy: new targets for antifungal therapy [J].
Andriole, VT .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 16 (03) :317-321
[3]   Trends in antifungal susceptibility among Candida sp urinary isolates from 1994 and 1998 [J].
Baran, J ;
Klauber, E ;
Barczak, J ;
Riederer, K ;
Khatib, R .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (02) :870-871
[4]   Etiology, clinical features and outcome of splenic microabscesses in HIV-infected patients with prolonged fever [J].
Bernabeu-Wittel, M ;
Villanueva, JL ;
Pachón, J ;
Alarcón, A ;
López-Cortés, LF ;
Viciana, P ;
Cadaval, F ;
Talegón, A .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1999, 18 (05) :324-329
[5]   Thirteen-year evolution of azole resistance in yeast isolates and prevalence of resistant strains carried by cancer patients at a large medical center [J].
Boschman, CR ;
Bodnar, UR ;
Tornatore, MA ;
Obias, AA ;
Noskin, GA ;
Englund, K ;
Postelnick, MA ;
Suriano, T ;
Peterson, LR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (04) :734-738
[6]   A new potent antifungal agent from Actinoplanes sp. [J].
Chu, M ;
Truumees, I ;
Mierzwa, R ;
Terracciano, J ;
Patel, M ;
Das, PR ;
Puar, MS ;
Chan, TM .
TETRAHEDRON LETTERS, 1998, 39 (42) :7649-7652
[7]   Sch 54445: A new polycyclic xanthone with highly potent antifungal activity produced by Actinoplanes sp. [J].
Chu, M ;
Truumees, I ;
Mierzwa, R ;
Terracciano, J ;
Patel, M ;
Loebenberg, D ;
Kaminski, JJ ;
Das, P ;
Puar, MS .
JOURNAL OF NATURAL PRODUCTS, 1997, 60 (05) :525-528
[8]   Xanthones, triterpenes and a biphenyl from Kielmeyera coriacea [J].
Cortez, DAG ;
Young, MCM ;
Marston, A ;
Wolfender, JL ;
Hostettmann, K .
PHYTOCHEMISTRY, 1998, 47 (07) :1367-1374
[9]  
da Costa CT, 2000, J MASS SPECTROM, V35, P540, DOI 10.1002/(SICI)1096-9888(200004)35:4<540::AID-JMS966>3.0.CO
[10]  
2-Y